Бізнес · 25.07.20181 хв читання
Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA or the Agency) is announcing a public hearing on FDA's approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products.